CIK 0001821825 · Large accelerated filer
Organon & Co.
Sign in to watch- Ticker
- OGN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 464838035
- Phone
- 551-430-6000
- Business address
- 30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-31 | Stahler Rachel A Chief Information Officer | Grant or award · Stock Option (right to buy) | +181,518 | 181,518 | ||
| 2025-03-31 | Stahler Rachel A Chief Information Officer | Grant or award · Restricted Stock Units | +36,937 | 36,937 | ||
| 2025-03-31 | Stahler Rachel A Chief Information Officer | Option exercise · Restricted Stock Units | −8,200 | 16,401 | ||
| 2025-03-31 | Stahler Rachel A Chief Information Officer | Option exercise · Restricted Stock Units | −6,555 | 6,555 | ||
| 2025-03-31 | Stahler Rachel A Chief Information Officer | Option exercise · Restricted Stock Units | −3,579 | 0 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Option exercise | +15,070 | 130,458 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −7,422 | $14.51 | $108K | 123,036 |
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Option exercise | +12,046 | 135,082 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −5,933 | $14.51 | $86K | 129,149 |
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Option exercise | +7,754 | 136,903 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Shares withheld for taxes | −3,819 | $14.51 | $55K | 133,084 |
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Stock Option (right to buy) | +317,656 | 317,656 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Grant or award · Restricted Stock Units | +64,640 | 64,640 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Option exercise · Restricted Stock Units | −15,070 | 30,142 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Option exercise · Restricted Stock Units | −12,046 | 12,047 | ||
| 2025-03-31 | WALSH MATTHEW M Chief Financial Officer | Option exercise · Restricted Stock Units | −7,754 | 0 | ||
| 2025-03-31 | Arjona Ferreira Juan Camilo Head of R&D & CMO | Option exercise | +8,865 | 20,552.36 | ||
| 2025-03-31 | Arjona Ferreira Juan Camilo Head of R&D & CMO | Shares withheld for taxes | −3,172 | $14.51 | $46K | 17,380.36 |
| 2025-03-31 | Arjona Ferreira Juan Camilo Head of R&D & CMO | Grant or award · Stock Option (right to buy) | +198,019 | 198,019 | ||
| 2025-03-31 | Arjona Ferreira Juan Camilo Head of R&D & CMO | Grant or award · Restricted Stock Units | +40,295 | 40,295 |
Page 14 of 18 · 351 trades